对于患有慢性甲状腺功能低下症的成年人来说,Palopegteriparatide:骨动力学通过2期paTH前进试验的3年
Mishaela R Rubin1, Bart L Clarke2, Lorenz C Hofbauer3
1Endocrinology, Columbia University, New York, NY, United States.
概括
在三年内,用于治疗小甲状腺功能障碍的佩洛佩格特里帕拉蒂德 (TransCon PTH) 治疗使水平正常化,骨密度改善. 这种疗法使患者能够停止常规治疗,这表明患者可以恢复到更自然的骨状态.
科学领域:
- 内分泌学 在内分泌学.
- 代谢性骨病 代谢性骨病
背景情况:
- 甲状腺功能低下症的特征是甲状腺侧腺激素 (PTH) 不足,破坏和酸盐平衡.
- 目前的管理通常涉及活性维生素D和补充剂,可能导致不理想的结果.
- 佩洛佩特里帕拉提德 (TransCon PTH) 为这种内分泌疾病提供了一种新的治疗方法.
研究的目的:
- 分析palopegteriparatide对骨矿物质密度 (BMD) 和骨周转标记物的长期影响.
- 为了评估血清和尿液水平在帕洛佩特里巴拉提德治疗期间的变化.
- 评估慢性偏偏甲状腺症的成年人与传统疗法治疗的独立性.
主要方法:
- 对PaTH Forward试验数据的分析,该试验涵盖了长达3年的palopegteriparatide治疗.
- 在腰椎,部,大腿部和半径处监测骨矿物质密度 (BMD).
- 测量血清骨循环标记物 (CTx,P1NP) 和血清/尿液水平.
主要成果:
- BMD Z-分数,最初高于正常水平,下降,但在162周,在所有测量地点保持阳性.
- 骨循环标志物显示过渡性增加,随后稳定在中度升高的水平,在正常范围内,大多数在第58周.
- 血清和尿液保持在正常范围内,有91%的参与者在162周内实现了与常规治疗的独立性.
结论:
- 长期的palopegteriparatide治疗低甲状腺功能障碍症逐渐使骨代谢恢复正常,恢复到自然状态.
- 该疗法有效地管理平衡,并减少对传统疗法的依赖.
- 佩洛佩特里帕拉提德具有良好的安全性,具有持续的生化控制和骨效益.
相关概念视频
01:11ortho–para-Directing Activators: –CH3, –OH, –NH2, –OCH3
7.5K
All ortho–para directors, excluding halogens, are activating groups. These groups donate electrons to the ring, making the ring carbons electron-rich. Consequently, the reactivity of the aromatic ring towards electrophilic substitution increases. For instance, the nitration of anisole is about 10,000 times faster than the nitration of benzene. The electron-donating effect of the methoxy group in anisole activates the ortho and para positions on the ring and stabilizes the corresponding...
7.5K
01:22Mean free path and Mean free time
5.2K
Consider the gas molecules in a cylinder. They move in a random motion as they collide with each other and change speed and direction. The average of all the path lengths between collisions is known as the "mean free path."
5.2K
01:21Path Between Thermodynamics States
4.0K
Consider the two thermodynamic processes involving an ideal gas that are represented by paths AC and ABC in Figure 1:
4.0K
01:10Interference: Path Lengths
2.2K
Consider two sources of sound, that may or may not be in phase, emitting waves at a single frequency, and consider the frequencies to be the same.
Two special sources may be considered when they are in phase. This can be easily achieved by feeding the two sources from the same source. An example would be synchronizing the two speakers by feeding them with the same source, such as the sound waves produced by a tuning fork. This setup ensures that the two sources have the same frequency and are...
Two special sources may be considered when they are in phase. This can be easily achieved by feeding the two sources from the same source. An example would be synchronizing the two speakers by feeding them with the same source, such as the sound waves produced by a tuning fork. This setup ensures that the two sources have the same frequency and are...
2.2K
02:31Phase Transitions
23.2K
Whether solid, liquid, or gas, a substance's state depends on the order and arrangement of its particles (atoms, molecules, or ions). Particles in the solid pack closely together, generally in a pattern. The particles vibrate about their fixed positions but do not move or squeeze past their neighbors. In liquids, although the particles are closely spaced, they are randomly arranged. The position of the particles are not fixed—that is, they are free to move past their neighbors to...
23.2K
01:11Clinical Trials: Overview
5.0K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
5.0K